We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Results from two phase 3 clinical trials recently ...

MARCY L’ETOILE, France--(BUSINESS WIRE)--Regulatory News: Today marks World Tuberculosis (TB) Day and bioMérieux (Paris:BIM), a world leader in the field of in vitro diagnostics, announces the CE ...

ATS 2016, SAN FRANCISCO - A new skin test for tuberculosis infection has proven safe, easy to administer and accurate in two Phase III clinical trials, according to research presented at the ATS 2016 ...

June 30, 2010 — The US Centers for Disease Control and Prevention (CDC) have issued updated guidelines for testing for Mycobacterium tuberculosis infection in adults and children using interferon ...

TB or tuberculosis is one disease that we as Indians have not been able to successfully eradicate. A disease that according to the World Health Organisation (WHO), in 2012, 8.6 million people suffered ...

Hsia and colleagues compared IGRA testing (QuantiFERON®-TB Gold (QFT-GIT; Cellestis, Inc.; Valencia, California) and TST testing (Mantoux) in 2282 patients enrolled in multinational phase 3 trials of ...

The goal of TB elimination, less than 1 case per million people per year, can only be achieved through a concerted effort to detect and treat persons infected with TB, which includes those persons ...

A significant technological shift which could redefine the business landscape in the latent TB testing market, is the growing interest in developing and refining IGRA tests. IGRA presents more ...

A new skin test for tuberculosis infection has proven safe, easy to administer and accurate in two Phase III clinical trials. A new skin test for tuberculosis infection has proven safe, easy to ...

Delray Beach, FL, Nov. 13, 2024 (GLOBE NEWSWIRE) -- The global Latent TB Testing market is projected to grow from USD 582.5 million in 2024 to USD 773.4 million by 2029, demonstrating a robust CAGR of ...